These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 23836321)

  • 1. Fraction of cell-free fetal DNA in the maternal serum as a predictor of abnormal placental invasion-a pilot study.
    Samuel A; Bonanno C; Oliphant A; Batey A; Wright JD
    Prenat Diagn; 2013 Nov; 33(11):1050-3. PubMed ID: 23836321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal plasma levels of cell-free β-HCG mRNA as a prenatal diagnostic indicator of placenta accrete.
    Zhou J; Li J; Yan P; Ye YH; Peng W; Wang S; Wang XT
    Placenta; 2014 Sep; 35(9):691-5. PubMed ID: 25063251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of abnormal placentation on maternal serum fetal fraction of cell-free DNA.
    Rodriguez M; Smith EL; Silva LM; Gultekin-Elbir EE; Tetla R; Genc MR
    J Perinat Med; 2023 Jan; 51(1):97-101. PubMed ID: 36383690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased placental and maternal serum TRAIL-R2 levels are associated with placenta accreta.
    Oztas E; Ozler S; Ersoy AO; Ersoy E; Caglar AT; Uygur D; Yucel A; Ergin M; Danisman N
    Placenta; 2016 Mar; 39():1-6. PubMed ID: 26992667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placenta accreta/percreta/increta: a cause of elevated maternal serum alpha-fetoprotein.
    Zelop C; Nadel A; Frigoletto FD; Pauker S; MacMillan M; Benacerraf BR
    Obstet Gynecol; 1992 Oct; 80(4):693-4. PubMed ID: 1383899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human placental lactogen mRNA in maternal plasma play a role in prenatal diagnosis of abnormally invasive placenta: yes or no?
    Li J; Zhang N; Zhang Y; Hu X; Gao G; Ye Y; Peng W; Zhou J
    Gynecol Endocrinol; 2019 Jul; 35(7):631-634. PubMed ID: 30784325
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between Number of Prior Cesareans and Early Preterm Delivery in Women with Abnormal Placentation.
    Oben A; Ausbeck EB; Gazi MN; Subramaniam A; Harper LM; Szychowski JM; Tita AT
    Am J Perinatol; 2021 Mar; 38(4):326-331. PubMed ID: 32992353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First trimester maternal serum biochemical markers of aneuploidy in pregnancies with abnormally invasive placentation.
    Thompson O; Otigbah C; Nnochiri A; Sumithran E; Spencer K
    BJOG; 2015 Sep; 122(10):1370-6. PubMed ID: 25639820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of abnormal placentation and hemorrhage in subsequent pregnancy following primary elective cesarean delivery.
    Chen S; Cheng W; Chen Y; Liu X
    J Matern Fetal Neonatal Med; 2020 Nov; 33(21):3608-3613. PubMed ID: 30741050
    [No Abstract]   [Full Text] [Related]  

  • 10. Abnormal placentation: twenty-year analysis.
    Wu S; Kocherginsky M; Hibbard JU
    Am J Obstet Gynecol; 2005 May; 192(5):1458-61. PubMed ID: 15902137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second Trimester Biochemical Markers as Possible Predictors of Pathological Placentation: A Retrospective Case-Control Study.
    Berezowsky A; Pardo J; Ben-Zion M; Wiznitzer A; Aviram A
    Fetal Diagn Ther; 2019; 46(3):187-192. PubMed ID: 30726846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased level of cell-free placental mRNA in a subgroup of placenta previa that needs hysterectomy.
    Miura K; Miura S; Yamasaki K; Yoshida A; Yoshiura K; Nakayama D; Niikawa N; Masuzaki H
    Prenat Diagn; 2008 Sep; 28(9):805-9. PubMed ID: 18646248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can the Cell-free DNA Test Predict Placenta Accreta Spectrum or Placenta Previa Totalis?
    Adiyaman D; Kuyucu M; Atakul BK; Can D; Özeren M; Koç A; Kutbay YB; Arıkan Ş; Öztekin D
    Z Geburtshilfe Neonatol; 2022 Apr; 226(2):92-97. PubMed ID: 34433209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of maternal serum Netrin-1 and Netrin-4 levels with placenta accreta spectrum.
    Kaya S; Turhan U; Dağ I; Polat I
    Eur Rev Med Pharmacol Sci; 2023 May; 27(10):4594-4600. PubMed ID: 37259741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First trimester serum PAPP-A is associated with placenta accreta: a retrospective study.
    Wang F; Chen S; Wang J; Wang Y; Ruan F; Shu H; Zhu L; Man D
    Arch Gynecol Obstet; 2021 Mar; 303(3):645-652. PubMed ID: 33515274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum angiogenic profile in abnormal placentation.
    Biberoglu E; Kirbas A; Daglar K; Biberoglu K; Timur H; Demirtas C; Karabulut E; Danisman N
    J Matern Fetal Neonatal Med; 2016 Oct; 29(19):3193-7. PubMed ID: 26863111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births.
    Eshkoli T; Weintraub AY; Sergienko R; Sheiner E
    Am J Obstet Gynecol; 2013 Mar; 208(3):219.e1-7. PubMed ID: 23313722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of targeted scanning protocols on perinatal outcomes in pregnancies at risk of placenta accreta spectrum or vasa previa.
    Melcer Y; Jauniaux E; Maymon S; Tsviban A; Pekar-Zlotin M; Betser M; Maymon R
    Am J Obstet Gynecol; 2018 Apr; 218(4):443.e1-443.e8. PubMed ID: 29353034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placenta accreta: depth of invasion and neonatal outcomes.
    Seet EL; Kay HH; Wu S; Terplan M
    J Matern Fetal Neonatal Med; 2012 Oct; 25(10):2042-5. PubMed ID: 22463851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Customizing EV-CATCHER to Purify Placental Extracellular Vesicles from Maternal Plasma to Detect Placental Pathologies.
    Mitchell MI; Khalil M; Ben-Dov IZ; Alverez-Perez J; Illsley NP; Zamudio S; Al-Khan A; Loudig O
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.